via University of East Anglia
Customised medicines could one day be manufactured to patients’ individual needs, with University of East Anglia (UEA) researchers investigating technology to 3D ‘print’ pills.
The team, including Dr Andy Gleadall and Prof Richard Bibb at Loughborough University, identified a new additive manufacturing method to allow the 3D printing of medicine in highly porous structures, which can be used to regulate the rate of drug release from the medicine to the body when taken orally.
Dr Sheng Qi, a Reader in Pharmaceutics at UEA’s School of Pharmacy, led the research. The project findings, ‘Effects of porosity on drug release kinetics of swellable and erodible porous pharmaceutical solid dosage forms fabricated by hot melt droplet deposition 3D printing’, are published today in the International Journal of Pharmaceutics.
Dr Qi said: “Currently our medicines are manufactured in ‘one-size-fits-all’ fashion.
“Personalised medicine uses new manufacturing technology to produce pills that have the accurate dose and drug combinations tailored to individual patients. This would allow the patients to get maximal drug benefit with minimal side effects.
“Such treatment approaches can particularly benefit elderly patients who often have to take many different types of medicines per day, and patients with complicated conditions such as cancer, mental illness and inflammatory bowel disease.”
The team’s work, Dr Qi said, is building the foundation for the technology needed in future to produce personalised medicine at the point-of-care. She said 3D printing has the unique ability to produce porous pharmaceutical solid dosage forms on-demand.
Pharmaceutical 3D printing research is a new research field that has rapidly developed in the past five years. Most commonly used 3D printing methods require the drug being processed into spaghetti-like filaments prior to 3D printing.
The team investigated a newly developed 3D printing method that can rapidly produce porous pharmaceutical tablets without the use of filaments. The results revealed that by changing the size of the pores, the speed of a drug escaping from the tablet into the body can be regulated.
Further research will be required in order to use the porosity to tailor the dose and dosing frequency (i.e. once daily or twice daily) of medicine to each patient’s needs, and use this principle to build multiple medicines into a single daily poly-pill for patients who are on a complex medicine regiment.
Original Article: PERSONALISED MEDICATIONS POSSIBLE WITH 3D PRINTING
More from: University of East Anglia | Loughborough University
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Customised medicines
- Physical activity found to improve early with customized text messages in patients with heart problems
Exercise is one of the best ways to reduce your risk of heart disease or having a second cardiovascular event, such as a heart attack or stroke.
- Custom duty cut on only three cancer medicines is not enough: Suneeta Reddy
Suneeta Reddy, Managing Director, Apollo Hospitals, in an exclusive conversation with Republic Business said that terms of tax realisation and reduction in custom duty for specific drugs are not ...
- Custom Health Celebrates the Launch of the Opioid Addiction Deterrence Task Force (OADTF) by the American Medical Technology Coalition
CEO of Custom Health and Executive Director of the American Medical Technology Coalition Shane Bishop announced the launch of the Opioid ...
- Union Budget slashes customs duty on three cancer drugs from 10 per cent to zero
Targeted therapy drugs, which cost around Rs 5 lakh a month, are holding out hope for patients as they prolong life by precisely identifying and inhibiting the growth of cancer cells. They are better ...
- Union Budget 2024 key highlights: Exempting customs duty on 3 cancer drugs, X-ray devices
The Finance Minister in her record seventh consecutive budget speech, announced the exemption of basic customs duty on three cancer care drugs: Trastuzumab Deruxtecan, Osimertinib, and Durvalumab, ...
Go deeper with Google Headlines on:
Customised medicines
[google_news title=”” keyword=”customised medicines” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
3D printing of medicines
- The potential of 3D printing in drug development and delivery
D printing is replacing traditional prototype development approaches across various industries, and use in healthcare is increasing fast.
- BioNTech signs 3D printing deal to develop oral RNA drugs
BioNTech is partnering with a 3D printing company to work on better delivering its RNA-based treatments. The Covid-19 vaccine maker is paying $10 million upfront to Triastek, a company based in ...
- Triastek and BioNTech to develop 3D-printed RNA therapeutics
"Triastek and BioNTech to develop 3D-printed RNA therapeutics" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.
- Beyond Beaches: Tampa’s Rise as a 3D Printing Powerhouse
Charles R. Goulding and Preeti Sulibhavi discover Tampa's transformation into a tech hub, driven by cutting-edge 3D printing technology revolutionizing its medical and maritime industries.
- Triastek Announces Research Collaboration and Platform Technology License Agreement with BioNTech to Advance 3D Printed Oral RNA Therapeutics
"We believe this collaboration stands as a promising milestone in advancing oral RNA therapeutics using 3D printing technology and aims to set new benchmarks in the development of large molecule oral ...
Go deeper with Google Headlines on:
3D printing of medicines
[google_news title=”” keyword=”3D printing of medicines” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
